Clinical Trials Logo

Skin Manifestations clinical trials

View clinical trials related to Skin Manifestations.

Filter by:

NCT ID: NCT06291415 Recruiting - Hemorrhage Clinical Trials

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

Start date: April 2, 2024
Phase: Phase 1
Study type: Interventional

This is an open-label, multicenter study to evaluate the safety, tolerability, and efficacy of HMPL-523 in adult subjects with ITP.

NCT ID: NCT06188338 Enrolling by invitation - Wrinkle Clinical Trials

A 56-day Clinical Study on Facial Skin Rejuvenation

Start date: November 18, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.

NCT ID: NCT06152718 Active, not recruiting - Skin Manifestations Clinical Trials

New Regenerative Approach for Dermal Renovation (Karisma)

Karisma
Start date: August 1, 2023
Phase:
Study type: Observational

Purpose/Objectives of the Study: Regenerative medicine, as well as aesthetic plastic surgery and dermatology field persistently seeks innovative, minimally invasive interventions to enhance skin quality and mitigate signs of aging. This study evaluates the regenerative capabilities of a new medical device focused on dermal redensification, induced by injections of single-strand alpha 1 collagen, to verify its ability, in a specific formulation (contained within a matrix of hyaluronic acid and carboxymethylcellulose), to induce dermal stimulation in both scar outcomes and regenerative medicine applied to skin aging.

NCT ID: NCT06140628 Active, not recruiting - Wrinkle Clinical Trials

A 28-day Clinical Study on Facial Skin Rejuvenation

Start date: September 24, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.

NCT ID: NCT05987163 Active, not recruiting - Skin Manifestations Clinical Trials

Study to Evaluate the Safety and Effectiveness of GP0116

NLF
Start date: April 12, 2023
Phase: N/A
Study type: Interventional

This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).

NCT ID: NCT05872178 Completed - Skin Manifestations Clinical Trials

Omegia Softgel Clinical Research Program

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel

NCT ID: NCT05819320 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Mucocutaneous Manifestations in Patients With Chronic Kidney Disease inNewVally and Assuit;Hospital Based Study

Start date: June 2024
Phase:
Study type: Observational [Patient Registry]

1. To study the patterns of mucocutaneous disorders in Chronic Kidney Disease patients in Eldakhla General Hospital, New Valley and in Assiut University hospital . 2. Comparison of the patterns of mucocutaneous manifestations and their correlation with the different stages of Chronic Kidney Disease in renal unit of internal medicine of Eldakhla general hospital in New Vally and pediatric and adult renal units of Assuit university hospital .

NCT ID: NCT05597254 Completed - Healthy Clinical Trials

Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation

Start date: September 26, 2022
Phase: N/A
Study type: Interventional

The goal of this double-blind randomized clinical trial is to investigate the effects on the skin from oral intake of probiotic supplements in healthy adult men and women. The main questions it aims to answer are: • Will probiotic supplementation result in beneficial changes to different skin parameters? • Will probiotic supplementation result in alterations in the skin microbiome? Participants will consume the study product daily for 8 weeks and come in for skin measurements at baseline and after 8 weeks.

NCT ID: NCT05235997 Recruiting - Wrinkle Clinical Trials

Placebo Controlled Efficacy Evaluation of the Hydrolyzed Collagen Peptide In Adult Females

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the contribution of hydrolized collagen products to elasticity, hydration and roughness of the skin of female volunteers. Safety and tolerability of the product is the other objective of this placebo-controlled, randomized study.

NCT ID: NCT05094687 Completed - COVID-19 Clinical Trials

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

Start date: July 31, 2020
Phase:
Study type: Observational [Patient Registry]

An outbreak of Corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) occurred in Wuhan city, Hubei province, China in December 2019. Pulmonary health has been the main focus of studies of COVID-19, current articles show that cutaneous signs appear in COVID-19 patients, their identification may be vital to early diagnosis and lead to possible better prognosis in COVID-19 patients